Blood substitutes and redox responses in the microcirculation

Antioxidants and Redox Signaling

Volumn 6, Issue 6, 2004, Pages 1019-1030

  Baldwin, Ann L ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; BLOOD SUBSTITUTE; DIASPIRIN CROSSLINKED HEMOGLOBIN; DIETHYLENETRIAMINE; ENZYME; HEMOGLOBIN; HORMONE; HYDROGEN PEROXIDE; IRON CHELATE; METHEMOGLOBIN; NITRIC OXIDE; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; OXYGEN; REACTIVE OXYGEN METABOLITE;

BLOOD SUBSTITUTION; BLOOD VESSEL FUNCTION; CELL CULTURE; CELL FREE SYSTEM; DRUG DELIVERY SYSTEM; ENDOTHELIUM CELL; ENZYME KINETICS; FLUID BALANCE; HUMAN; INTERSTITIUM; KINETICS; MICROCIRCULATION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; OXYGEN TRANSPORT; PLASMA; PRIORITY JOURNAL; PROTECTION; REOXYGENATION; REVIEW; SIGNAL TRANSDUCTION; TISSUE INJURY; TRANSFUSION;

ANIMALS; ANTIOXIDANTS; BLOOD SUBSTITUTES; ENDOTHELIUM, VASCULAR; HEMOGLOBINS; HUMANS; MAST CELLS; MICROCIRCULATION; MODELS, BIOLOGICAL; MODELS, CHEMICAL; NITRIC OXIDE; OXIDATION-REDUCTION; OXYGEN; PERMEABILITY; REACTIVE OXYGEN SPECIES;

EID: 7244219949     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2004.6.1019     Document Type: Review

References (96)

1. Al-Naemi H and Baldwin AL. Nitric oxide: role in venular permeability recovery after histamine challenge. Am J Physiol 277: H2010-H2016, 1999.
2. Baldwin AL. Blood substitutes and the intestinal microcirculation: extravasation and ultrastructural alterations. In: Advances in Blood Substitutes: Industrial Opportunities and Medical Challenges, edited by Winslow RM, Vandergrif KD, and Intaglietta M. Boston, MA: Birkhauser, 1997, pp. 19-37.
3. Baldwin AL. Modified hemoglobins produce venular interendothelial gaps and albumin leakage in the rat mesentery. Am J Physiol 277: H650-H659, 1999.
4. Baldwin AL and Thurston G. Changes in endothelial actin cytoskeleton in venules with time after histamine treatment. Am J Physiol 269: H1528-H1537, 1995.
5. Baldwin AL and Wiley EB. Selenium reduces hemoglobin-induced damage to intestinal mucosa. Artif Cells Blood Substit Immobil Biotechnol 30: 1-22, 2002.
6. Baldwin AL, Wilson LM, and Valeski JE. Ultrastructural effects of intravascularly injected polyethylene glycolhemoglobin in intestinal mucosa. Am J Physiol 275: H615-H625, 1998.
7. Baldwin AL, Thurston G, and Al Naemi H. Inhibition of nitric oxide synthesis increases venular permeability and alters endothelial actin cytoskeleton. Am J Physiol 274: H1776-H1784, 1998.
8. Baldwin AL, Wiley EB, Mata JE, and Iversen P. Effects of PS-ODN on hemoglobin-induced microvascular leakage in rat mesentery. (Abstract) FASEB J 16: 410.19, A511, 2002.
9. Baldwin AL, DeMaria L, Wiley EB, Mata JE, and Iversen P. Effects of PS-ODN on hemoglobin-induced damage of rat intestinal mucosa. (Abstract) FASEB J 16: 873.3, A1166, 2002.
10. 2 carriers on intestinal integrity and microvascular leakage. Am J Physiol 283: H1292-H1301, 2002.
11. Baldwin AL, Wiley EB. Summers AG, and Alayash AI. Sodium selenite reduces hemoglobin-induced venular leakage in the rat mesentery. Am J Physiol 284: H81-H91, 2003.
12. Baldwin AL, Cudilo E, Riggs J, and Alayash A. Nitric oxide reduces hemoglobin-induced venular leaks but not mast cell degradation. (Abstract). FASEB J 17: 101.23, A135, 2003.
13. Baldwin AL, Wiley EB, and Alayash AI. Differential effects of sodium selenite in reducing tissue damage caused by three hemoglobin-based oxygen carriers. J Appl Physiol 96: 893-903, 2004.
14. Balla J, Jacob HS, Balla G, Nath K, Eaton JW, and Vercellotti GM. Endothelial cell heme uptake from heme proteins: induction of sensitization and desensitization to oxidant damage. Proc Natl Acad Sci USA 90: 9285-9289, 1993.
15. Blum J and Fridovich I. Inactivation of glutathione peroxidase by Superoxide radical. Arch Biochem Biophys 240: 500-508, 1985.
16. Bolin R, Smith D, Moore G, Boswell G, and DeVenuto F. Hematologic effects of hemoglobin solutions in animals. Prog Clin Biol Res. 122: 117-126, 1983.
17. Bolli R, Patel BS, Zhu WX, O'Neill PG, Hartley Cl, Charlat ML, and Roberts R. The iron chelator desferrioxamine attenuates postischemic ventricular dysfunction. Am J Physiol 253: H1372-H1380, 1987.
18. Burhop KE and Estep TE. Hemoglobin-induced myocardial lesions. In: VIII International Symposium an Blood Substitutes (ISBS) San Diego, Abstract, 2000. p. 21.
19. Burnham NL. Polymers for delivering peptides and proteins. Am J Hosp Pharm 51: 210-218, 1994.
20. Carter WO, Narayanan PK, and Robinson JP. Intracellular hydrogen peroxide and Superoxide anion detected in endothelial cells. J Leukoc Biol 55: 253-258, 1994.
21. Chen C-Y and Lin T-H. Effects of selenium dioxide on blood and femoral bone marrow of rats. J Toxicol Environ Health A 59: 553-560, 2000.
22. Comair YG, Schipper HM, and Brem S. The prevention of oxyhemoglobin-induced endothelial and smooth muscle cytoskeletal injury by deferoxamine. Neurosurgery 32: 58-64, 1993.
23. D'Agnillo F and Alayash A. Site-specific modifications and toxicity of blood substitutes. The case of diaspirin cross-linked hemoglobin. Adv Drug Deliv Rev 40: 199-212, 2000.
24. D'Agnillo F and Alayash AI. Redox cycling of diaspirin cross-linked hemoglobin induces G2/M arrest and apoptosis in cultured endothelial cells. Blood 98: 3315-3323, 2001.
25. D'Agnillo F and Chang TM. Cross-linked hemoglobin-superoxide dismutase-catalase scavenges oxygen-derived free-radicals and prevents methemoglobin formation and iron release. Biomater Artif Cells Immobilization Biotechnol 21: 609-621, 1993.
26. D'Agnillo F, Wood F, Porras C, Macdonald VW, and Alayash AI. Effects of hypoxia and glutathione depletion on hemoglobin- and myoglobin-mediated oxidative stress toward endothelium. Biochim Biophys Acta 1495: 150-159, 2000.
27. Dorman SC, Kenny CF, Miller L, Hirsch RE, and Harrington JP. Role of redox potential of hemoglobin-based oxygen carriers on methemoglobin reduction by plasma components. Artif Cells Blood Substit Immobil Biotechnol 30: 39-51, 2002.
28. Faivre B, Labaeye V, Menu P, Labrude P, and Vigneron C. Assessment of dextran 10-benzene-tetracarboxylate-hemoglobin, an oxygen carrier, using guinea pig isolated bowel model. Artif Cells Blood Submit Immobil Biotechnol 23:495-504, 1994.
29. Farber JL, Kyle ME, and Coleman JB. Mechanisms of cell injury by activated oxygen species. Lab Invest 62: 670-679, 1990.
30. Feola M, Simioni J, Dobke M, and Canizaro PC. Complement activation and the toxicity of stroma-free hemoglobin solutions in primates. Circ Shock 25: 275-290, 1988.
31. Fox J, Galcy F, and Wayland H. Action of histamine on the mesenteric microvasculature. Microvasc Res 19: 108-126, 1980.
32. Giulivi C, Romero FJ, and Cadenas E. The interaction of Trolox C, a water-soluble vitamin E analog, with ferrylmyoglobin: reduction of the oxoferryl moiety. Arch Biochem Biophys 299: 302-312, 1992.
33. Granger DN, Rutili G, and McCord JM. Superoxide radicals in feline intestinal ischemia. Gastroenterology 81: 22-29, 1981.
34. Grisham MB and Everse J. Peroxidases in Chemistry and Biology. Boca Raton, FL: CRC Press, 1991, pp. 335-344.
35. Gutteridge JMC. Iron promoters of the Fenton reaction and lipid peroxidation can be released from haemoglobin by peroxides. FEBS Lett 201: 291-295, 1986.
36. Halliwell B. Oxidants and human disease: some new concepts. FASEB J 1: 358-364, 1987.
37. Halliwell B. Protection against tissue damage in vivo by desferrioxamine: what is its mechanism of action? Free Radic Biol Med 7: 645-651, 1989.
38. Halliwell B. Reactive oxygen species in living systems: source, biochemistry, and role in human disease. Am J Med 91: 14S, 1991.
39. Halliwell B and Gutteridge JMC. Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts. Arch Biochem Biophys 246: 501-514, 1986.
40. Henderson LM and Chappell JB. Dihydrorhodamine 123: a fluorescent probe for Superoxide generation? Eur J Biochem 217: 973-980, 1993.
41. Hess JR. Blood substitutes for surgery and trauma; efficacy and toxicity issues. BioDrugs 12: 81-90, 1999.
42. Horan KL, Adamski SW, Ayele W, Langone JJ, and Grega GJ. Evidence that prolonged histamine suffusions produce transient increases in vascular permeability subsequent to formation of venular macromolecular leakage sites. Am J Pathol 123: 570-576, 1986.
43. Lalente A, Ignaro A, Moncada S, and Rosa MD. Modulation of acute inflammation by endogenous nitric oxide. Eur J Pharmacol 211: 177-182, 1992.
44. Jornot L and Junod AF. Variable glutathione levels and expression of antioxidant enzymes in human endothelial cells. Am J Physiol 264: L482-L489, 1993.
45. Kontoghiorghes GJ, Aldouri MA, Hoffbrand AV, Barr J, Wonke B, Kourouclaris T, and Sheppard L. Effective chelation of iron in β-thalassaemia with the novel chelator 1,2-dimethyl-3-hydroxypyrid-4-one. Br Med J 295: 1509-1512, 1987.
46. -. or as SOD mimics? J Biol Chem 271: 26026-26031, 1996.
47. Kubes P and Granger DN. Nitric oxide modulates microvascular permeability. Am J Physiol 262: H611-H615, 1992.
48. Kubes P, Kanwar S, Niu X-F, and Gaboury JP. Nitric oxide synthesis inhibition induces leukocyte adhesion via superoxide and mast cells. FASEB J 7: 1293-1299, 1993.
49. Kurose I, Kubes P, Wolf R, Anderson DC, Paulson J, Miyasaka M, and Granger DN. Inhibition of nitric oxide production. Mechanisms of vascular leakage. Circ Rex 73: 164-171, 1993.
50. Lee R, Neya K, Svizzero TA, and Vlahakes GJ. Limitations of the efficacy of hemoglobin-based oxygen carrying solutions. J Appl Physiol 79: 236-242, 1995.
51. Linberg R, Conover CD, Shum KL, and Shorr RGL. Hemoglobin-based oxygen carriers: how much methemoglobin is too much? Artif Cells Blood Substit Immobil Biotechnol 26: 133-148, 1998.
52. Makropoulos V, Bruning T, and Schulze-Osthoff K. Selenium-mediated inhibition of transcription factor NF-κB and HIV-1 LTF promoter activity. Arch Toxicol 70: 277-283, 1996.
53. Marczin N, Ryan US, and Catravas JD. Effects of oxidant stress on endothelium-derived relaxing factor-induced and nitro-vasodilator-induced cGMP accumulation in vascular cells in culture. Circ Res 70: 326-340, 1992.
54. Mata JE, Bishop MR, Tarantolo SR, Angel CR, Swanson SA, and Iversen PL. Evidence of enhanced iron excretion during systemic phosphorothioate oligodeoxynucleotide treatment. Clin Toxicol 38: 383-387, 2000.
55. Mayhan WG. Role of nitric oxide in modulating permeability of hamster cheek pouch in response to adenosine 5′-phosphate and bradykinin. Inflammation 16: 295-305, 1992.
56. McCarty MF. Oxidants downstream from Superoxide inhibit nitric oxide production by vascular endothelium - a keynote for selenium-dependent enzymes in vascular health. Med Hypotheses 53: 315-325, 1999.
57. Miller FN, Joshua IG, and Anderson GL. Quantitation of vasodilator-induced macromolecular leakage by in vivo fluorescent microscopy. Microvasc Res 24: 56-67, 1982.
58. Misra HP and Fridovich I. The generation of Superoxide radical during the autooxidation of hemoglobin. J Biol Chem 247: 6960-6962, 1972.
59. Moison RMW, van Hoof EJHA, Clahsen PC, van Zoeren-Grobben D, and Berger HM. Influence of plasma preparations and donor red blood cells on the antioxidant capacity of blood from newborn babies: an in vitro study. Acta Paediatr 85: 220-224, 1996.
60. Moncada S. The L-arginine oxide pathway. Acta Physiol Scand 145: 201-227, 1992.
61. Motterlini R, Foresti R, Vandergriff K, and Intaglietta M. Oxidative stress response in endothelial cells exposed to acellular hemoglobin solutions. Am J Physiol 269: H648-H655, 1995.
62. Motterlini R, Foresti R, Vandergriff K, and Winslow RM. The autoxidation of ααcross-linked hemoglobin: a possible role in the oxidative stress to endothelium. Artif Cells Blood Substit Immobil Biotechnol 23: 291-301, 1995.
63. Nagababu E, Somasundaram R, and Rifkind JM. Site-specific cross-linking of human and bovine hemoglobins differentially alters oxygen binding and redox side reactions producing rhombic heme and heme degradation. Biochemistry 41: 7407-7415, 2002.
64. Nolle D, Botzlar A, Pickelmann S, Bouskela E, and Messmer K. Effects of diaspirin-cross-linked hemoglobin (DCLHb) on the microcirculation of striated skin muscle in the hamster: a study on safety and toxicity. J Lab Clin Med 130: 314-327, 1997.
65. Nossuli TO, H ay ward R, Jenscn D, Scalia R, and Lefer AM. Mechanisms of cardioprotection by peroxynitritc in myocardial ischemia and reperfusion injury. Am J Physiol 275: H509-H519, 1998.
66. Olivier JA. Endothelium-derived relaxing factor contributes to the regulation of endothelial permeability. J Cell Physiol 151: 506-511, 1992.
67. Paller MS. Hemoglobin- and myoglobin-induced acute renal failure in rats: role of iron in nephrotoxicity. Am J Physiol 255: F539-F544, 1988.
68. Pearce BL and Gawryl MS. Overview of preclinical and clinical efficacy of Biopure's HBOCs. In: Blood Substitutes: Principles, Methods, Products and Clinical Trials, Vol. II, edited by Chang TMS. Basel, Switzerland: Karger Landes Systems, 1998, pp. 82-100.
69. Przybelski R, Daily EK, Kisicki JC, Mattia-Goldberg C, Bounds MJ, and Colburn WA. Pharmacologic profile of diaspirin cross-linked hemoglobin solution. Crit Care Med 24: 1993-2000, 1996.
70. Puppo A and Halliwell B. Formation of hydroxyl radicals from hydrogen peroxide in the presence of iron: is haemoglobin a biological Fenton catalyst? Biochem J 249: 185-190, 1988.
71. Razak S, D'Agnillo F, and Chang TMS. Crosslinked hemoglobin-superoxide dismutase-catalase scavenges free radicals in a rat model of intestinal ischemia-reperfusion injury. Artif Cells Blood Substit Immobil Biotechnol 25: 181-192, 1997.
72. Rogers MS, Brocknor B, Cashon RE, and Alayash AI. Effects of polymerization on the oxygen carrying and redox properties of diaspirin cross-linked hemoglobin. Biochim Biophys Acta 1248: 135-142, 1995.
73. Sadrzadch SMH, Graf E, Panter SS, Hallaway PE, and Eaton JW. Hemoglobin. A biologic fenton reagent. J Biol Chem 259: 14354-14356, 1984.
74. Saetzler RK, Arfors KE, Tuma RF, Vasthare U, Ma L, Hsia CJC, and Lehr H-A. Polynitroxylated hemoglobin-based oxygen carrier: inhibition of free radical-induced microcirculatory dysfunction. Free Radic Biol Med 27: 1-6, 1999.
75. Seibert AF, Taylor AE, Bass JB, and Haynes J. Hemoglobin potentiates oxidant injury in isolated rat lungs. Am J Physiol 260: H1980-H1984, 1991.
76. Seko Y, Saito Y, Kitihara J, and Imura N. Active oxygen generation by the reaction of selenite with reduced glutathione in vitro. In: Selenium in Biology and Medicine, edited by Wendel A. New York: Springer-Verlag, 1989, pp. 70-73.
77. Simoni J, Simoni G, Lox CD, and Feola M. Reaction of human endothelial cells to bovine hemoglobin solutions and tumor necrosis factor. Artif Cells Blood Substit Immobil Biotechnol 22: 777-787, 1994.
78. Simoni J, Simoni G, Garcia EL, Prien SD, Tran RM, Feola M, and Shires GT. Protective effect of selenium on hemoglobin mediated lipid peroxidation in vivo. Artif Cells Blood Substit Immobil Biotechnol 23(4): 469-486, 1995.
79. Simoni J, Simoni G, Lox CD, Prien SD, and Shires GT. Modified hemoglobin solution, with desired pharmacological properties, does not activate nuclear transcription factor NF-kappa B in human vascular endothelial cells. Artif Cells Blood Substit Immobil Biotechnol 25: 193-210, 1997.
80. Sloan ER, Koenigsberg M, Gens D, Cipolle M, Runge J, Mullory M, and Rodman G. Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhage shock: a randomized controlled efficacy trial. JAMA 282: 1857-1864, 1999.
81. Smith JK, Garden DL, Grisham MB, Granger DN, and Korthius RJ. Role of iron in postischemic microvascular injury. Am J Physiol 256: H1472-H1477, 1989.
82. Suzuki YJ, Forman HJ and Sevanian A. Oxidants as stimulators of signal transduction. Free Radic Biol Med 22: 269-285, 1997.
83. Svensjo E and Joyner WL. The effects of intermittent and continuous stimulation of microvessels in the cheek pouch of hamsters with histamine and bradykinin on the development of venular leaky sites. Microcirc Endothelium Lymphatics 1: 381-396, 1984.
84. Tappel AL. Glutathione peroxidase and its seleno-cysteine active sites. In: Selenium in Biology and Medicine, edited by Spallholz JE, Martin JL and Ganther HE. Westport, CT: Avi Publishing Company, 1981. pp. 44-53.
85. Teixcira MM, William TJ, and Hellewell PG. Role of prostaglandins and nitric oxide in acute inflammatory reactions in guinea-pig skin. Br J Pharmacol 110: 1515-1521, 1993.
86. - efflux which injures endothelial cells by an extracellular mechanism. Am J Physiol 270: H945-H950, 1996.
87. Thiemermann C, McDonald MC, and Cuzzocrea S. The stable nitroxide. Tempol, attenuates the effects of peroxynitrite and oxygen-derived free radicals. Crit Care Med 29: 223-224, 2001.
88. Thompson A, McGarry AE, Valeri CR, and Lieberthal W. Stroma-free hemoglobin increases blood pressure and GFR in the hypotensive rat: role of nitric oxide. J Appl Physiol 77: 2348-2354, 1994.
89. Thurston G, Baldwin AL, and Wilson LM. Changes in endothelial actin cytoskeleton at leakage sites in the rat mesenteric microvasculature. Am J Physiol 266: H316-H329, 1995.
90. Vercelloti GM, Balla G, Balla J, Nath K, Eaton JW, and Jacob HS. Heme and the vasculature: an oxidative hazard that induces antioxidant defenses in the endothelium. Artif Cells Blood Substit Immobil Biotechnol 22: 207-213, 1994.
91. Wever RB, Oudega B, and Van Gelder BF. Generation of Superoxide radicals during the autoxidation of mammalian oxyhemoglobin. Biochim Biophys Acta 302: 475-478, 1973.
92. Wilson LM and Baldwin AL. Environmental stress causes mast cell degranulation, endothelial and epithelial changes, and edema in the rat intestinal mucosa. Microcirculation 6: 189-198, 1999.
93. Wu N and Baldwin AL. Transient venular permeability increase and endothelial gap formation induced by histamine. Am J Physiol 262: H1238-H1247, 1992.
94. Yamada T, Volkmer C, and Grisham MB. The effects of sulfasalazine metabolites on hemoglobin-catalyzed lipid peroxidation. Free Radic Biol Med 10: 41-49, 1991.
95. Yang T and Olsen KW. The effect of crosslinking by bis(3,5- dibromosalicyl) fumarate on the autoxidation of hemoglobin. Biochem Biophys Res Commun 163: 733-738, 1989.
96. Yang W and Block ER. Effect of hypoxia and reoxygenation on the formation and release of reactive oxygen species by porcine pulmonary artery endothelial cells. J Cell Physiol 164: 414-423, 1995.